Randomized Trial Comparing Early "Trigger" Versus Delayed "Trigger" Timing in Cycles of Controlled Ovarian Stimulation.
NCT05498350 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2022-08-12
Summary
This randomized trial will compare the efficacy of two different times of administration of medications for final oocyte maturation, commonly called a "trigger", in cycles of controlled ovarian stimulation (COS) for cycles in which all embryos will be cryopreserved ("freeze-all cycles").
Conditions
- Infertility, Female
Interventions
- PROCEDURE
-
Ovulatory trigger timing
Timing of medication to induce final oocyte maturation
Sponsors & Collaborators
-
Fertility Center of Las Vegas
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 34 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-10
- Primary Completion
- 2024-08-31
- Completion
- 2025-11-30
Countries
- United States
Study Locations
More Related Trials
-
Double Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory Follicles
NCT04407065 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Dual Trigger Ovulation in Oocyte Donors
NCT01443546 ·Status: TERMINATED ·Phase: PHASE4
-
Type of Gonadotropin and Embryo Kinetics of Development
NCT02402192 ·Status: TERMINATED ·Phase: PHASE4
-
Double Trigger in Patients With Low Proportion of Mature Oocytes
NCT04407052 ·Status: UNKNOWN ·Phase: PHASE2
-
Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization
NCT02322398 ·Status: COMPLETED
-
Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders
NCT04224818 ·Status: COMPLETED ·Phase: PHASE3
-
Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation
NCT02703584 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin & IUI
NCT02510534 ·Status: TERMINATED ·Phase: PHASE1
-
Gonadotropin Type in Ovarian Stimulation
NCT02437032 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Medication Used to Stimulate Ovulation
NCT02715336 ·Status: UNKNOWN ·Phase: PHASE4
-
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
NCT00439829 ·Status: COMPLETED ·Phase: PHASE4
-
GnRH Agonist and Intrauterine Insemination
NCT00503217 ·Status: COMPLETED ·Phase: PHASE4
-
Dual Trigger for Elective Fertility Preservation
NCT04992468 ·Status: COMPLETED ·Phase: PHASE4
-
Earlier Triggering in Rec-FSH/GnRH Antagonist Cycles
NCT01390207 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dual Triggering in Patients With a High Immature Oocyte Rate
NCT02813239 ·Status: COMPLETED
-
Trigger Timing in Ovarian Stimulations
NCT04163133 ·Status: RECRUITING ·Phase: NA
-
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
NCT01669291 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenetic Algorithm for Individualized Controlled Ovarian Stimulation
NCT03149536 ·Status: UNKNOWN ·Phase: NA
-
Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles
NCT02310919 ·Status: COMPLETED ·Phase: PHASE3
-
Mono-menotropins Versus rFSH Protocol on Embryo Quality
NCT02418533 ·Status: COMPLETED ·Phase: NA
-
Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian Reserve
NCT02128360 ·Status: UNKNOWN ·Phase: NA
-
A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation
NCT02449889 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes
NCT01979341 ·Status: WITHDRAWN ·Phase: NA
-
A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment
NCT01426386 ·Status: COMPLETED ·Phase: PHASE2
-
GnRH Agonist for Luteal Phase Support.
NCT05484193 ·Status: UNKNOWN ·Phase: NA